Efficacy and safety of adalimumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study

C. Fabiani, A. Vitale, Giacomo Emmi, Lorenzo Vannozzi, Giuseppe Lopalco, S. Guerriero, Ida Orlando, R. Franceschini, Daniela Bacherini, L. Cimino, A. Soriano, B. Frediani, M. Galeazzi, F. Iannone, Gian Marco Tosi, C. Salvarani, L. Cantarini

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)183-189
Number of pages7
JournalClinical Rheumatology
Volume36
Issue number1
DOIs
Publication statusPublished - 2017

Cite this

Fabiani, C., Vitale, A., Emmi, G., Vannozzi, L., Lopalco, G., Guerriero, S., Orlando, I., Franceschini, R., Bacherini, D., Cimino, L., Soriano, A., Frediani, B., Galeazzi, M., Iannone, F., Tosi, G. M., Salvarani, C., & Cantarini, L. (2017). Efficacy and safety of adalimumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study. Clinical Rheumatology, 36(1), 183-189. https://doi.org/10.1007/s10067-016-3480-x